HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Xia Selected Research

cheongseoikki-tang

12/2021Clinical efficacy and safety of Qingshu Yiqi decoction as a complementary and alternative therapy for COVID-19 with Delta variant: A protocol for systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Xia Research Topics

Disease

118Neoplasms (Cancer)
10/2022 - 12/2005
20Renal Cell Carcinoma (Grawitz Tumor)
11/2021 - 01/2015
16Infections
12/2022 - 12/2007
16Inflammation (Inflammations)
11/2022 - 04/2010
13Neoplasm Metastasis (Metastasis)
01/2022 - 11/2013
12Hepatocellular Carcinoma (Hepatoma)
05/2021 - 01/2008
9Breast Neoplasms (Breast Cancer)
01/2021 - 05/2011
8Obesity
07/2022 - 11/2015
7Adenocarcinoma of Lung
10/2021 - 10/2017
7Lung Neoplasms (Lung Cancer)
01/2021 - 11/2018
6Virus Diseases (Viral Diseases)
01/2022 - 12/2009
6Atrial Fibrillation
12/2021 - 10/2015
6Urinary Bladder Neoplasms (Bladder Cancer)
11/2021 - 12/2019
6Type 2 Diabetes Mellitus (MODY)
09/2021 - 01/2019
6Carcinoma (Carcinomatosis)
01/2020 - 01/2010
5Insulin Resistance
09/2021 - 01/2017
5Ovarian Neoplasms (Ovarian Cancer)
06/2021 - 01/2017
5Mitochondrial Diseases (Mitochondrial Disease)
12/2020 - 01/2020
5Hypoxia (Hypoxemia)
07/2020 - 10/2013
5Melanoma (Melanoma, Malignant)
01/2020 - 05/2009
5Fibrosis (Cirrhosis)
10/2018 - 10/2013
5Asthma (Bronchial Asthma)
01/2017 - 06/2009
4Wounds and Injuries (Trauma)
12/2022 - 01/2013
4Pneumonia (Pneumonitis)
10/2022 - 10/2015
4Rupture
03/2022 - 03/2014
4Body Weight (Weight, Body)
01/2022 - 08/2019
4Stroke (Strokes)
11/2021 - 01/2019
4Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 01/2017
4Metabolic Diseases (Metabolic Disease)
06/2021 - 08/2019
4Lymphatic Metastasis
02/2021 - 11/2009
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 08/2018
4Parkinson Disease (Parkinson's Disease)
01/2020 - 12/2017
4Hemorrhage
01/2019 - 11/2014
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2022 - 01/2020
3Heart Failure
04/2022 - 11/2012
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 02/2021
3Hyperplasia
01/2022 - 01/2017
3Stomach Neoplasms (Stomach Cancer)
02/2021 - 11/2013
3Lymphopenia (Lymphocytopenia)
01/2021 - 04/2010
3Hematologic Neoplasms (Hematological Malignancy)
10/2020 - 03/2014
3Liver Cirrhosis (Hepatic Cirrhosis)
06/2020 - 11/2017
3Sarcoma (Soft Tissue Sarcoma)
01/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
07/2021 - 05/2008
25Pharmaceutical PreparationsIBA
05/2022 - 08/2009
19LipidsIBA
07/2022 - 02/2014
19SeleniumIBA
05/2021 - 12/2015
18CytokinesIBA
12/2022 - 12/2007
17Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2015
11Small Interfering RNA (siRNA)IBA
05/2021 - 05/2011
7MicroRNAs (MicroRNA)IBA
01/2022 - 01/2018
7Peptides (Polypeptides)IBA
01/2022 - 01/2016
7Tyrosine Kinase InhibitorsIBA
11/2021 - 11/2016
7Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 02/2014
6Therapeutic UsesIBA
01/2022 - 11/2017
6Messenger RNA (mRNA)IBA
01/2022 - 01/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2020
5RNA (Ribonucleic Acid)IBA
01/2022 - 01/2016
5Long Noncoding RNAIBA
01/2022 - 11/2018
5CollagenIBA
01/2022 - 10/2011
5Indicators and Reagents (Reagents)IBA
12/2021 - 01/2020
5LigandsIBA
06/2021 - 01/2016
5IronIBA
03/2021 - 05/2008
5PolymersIBA
01/2020 - 05/2011
5DNA (Deoxyribonucleic Acid)IBA
08/2018 - 07/2002
4Immune Checkpoint InhibitorsIBA
10/2022 - 01/2019
4Antiviral Agents (Antivirals)IBA
01/2022 - 10/2015
4ClathrinIBA
12/2020 - 12/2015
4Fatty Acids (Saturated Fatty Acids)IBA
08/2019 - 12/2011
4Dextrans (Dextran)FDA Link
01/2019 - 12/2011
4Interleukin-4 (Interleukin 4)IBA
10/2018 - 04/2008
4Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA
12/2011 - 12/2007
3Antiphospholipid AntibodiesIBA
12/2022 - 01/2020
3IonsIBA
12/2022 - 03/2014
3Metalloproteases (Metalloproteinases)IBA
12/2022 - 05/2013
3Fibroblast Growth Factor-23IBA
01/2022 - 01/2020
3Nucleic AcidsIBA
12/2021 - 06/2013
3Biological ProductsIBA
01/2021 - 01/2018
3InflammasomesIBA
01/2021 - 01/2019
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2018
3Phosphotransferases (Kinase)IBA
01/2021 - 12/2016
3LuciferasesIBA
11/2020 - 05/2011
3AcidsIBA
06/2020 - 10/2012
3Matrix Metalloproteinases (MMPs)IBA
05/2020 - 03/2017
3shenqiIBA
02/2020 - 10/2017
3Hyaluronic Acid (Hyaluronan)IBA
01/2020 - 01/2018
3CholesterolIBA
01/2020 - 11/2014
3VaccinesIBA
01/2020 - 04/2008
3Insulin (Novolin)FDA Link
11/2019 - 01/2019
3IsoflavonesIBA
08/2019 - 03/2019
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 11/2009
3sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2019 - 06/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 04/2008
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019 - 02/2010

Therapy/Procedure

46Therapeutics
01/2022 - 04/2008
15Drug Therapy (Chemotherapy)
03/2021 - 12/2005
10Immunotherapy
01/2022 - 01/2020
5Length of Stay
12/2021 - 01/2013
4Extracorporeal Membrane Oxygenation
04/2022 - 01/2019
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2017
4Nephrectomy
05/2019 - 09/2015